INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, published by Taylor & Francis Ltd, has established itself as a premier forum for the dissemination of innovative research related to radiation biology, covering emerging topics that are crucial within the fields of radiology, nuclear medicine, and ultrasound technology. With an ISSN of 0955-3002 and an E-ISSN of 1362-3095, this journal spans over six decades, from its inception in 1959 to 2024, reflecting a rich history of scholarly contribution and a dynamic approach to addressing current challenges in the discipline. Its reputation is highlighted by its Q2 rankings in both Radiology, Nuclear Medicine and Imaging and Radiological and Ultrasound Technology for 2023, underscoring its relevance in a competitive academic landscape, with Scopus rankings placing it in the top tier of its category. While operating under a traditional access model, the journal aims to connect researchers, professionals, and students, facilitating the advancement of knowledge and fostering a deeper understanding of the impact of radiation in various medical applications. The journal plays an essential role in shaping future research directions and enhancing clinical practices globally.

The International Journal of Radiation Research, published by the IJRR-IRANIAN JOURNAL RADIATION RES, serves as a critical platform for researchers and professionals in the fields of radiology, nuclear medicine, and imaging technology. Since its inception in 2003, this peer-reviewed, open-access journal has focused on disseminating significant findings and advancements, contributing to the global discourse on radiation research. With an ISSN of 2322-3243, the journal offers valuable insights into emerging technologies and methodologies, maintaining a commitment to enhancing the understanding and application of radiation in medical science. Although currently positioned in the Q4 category across its scopes, the journal strives to elevate its impact by promoting high-quality research and innovative practices. The journal is accessible to a wide audience and encourages submissions from scholars worldwide, directly supporting the advancement of knowledge in radiological and ultrasound technology. For those seeking to explore and contribute to this dynamic field, the International Journal of Radiation Research represents an invaluable resource.

Medical Dosimetry is a distinguished journal published by Elsevier Science Inc, dedicated to the advancing field of medical dosimetry and its applications within oncology, radiology, and nuclear medicine. With its ISSN 0958-3947 and E-ISSN 1873-4022, this journal serves as a crucial resource for researchers and professionals aiming to enhance their understanding of radiation treatment planning and dosage calculations. Encompassing a comprehensive range of topics from clinical dosimetry to technology assessment, Medical Dosimetry has been disseminating significant findings since its establishment in 1988, contributing to the continuous development of best practices in patient care and safety. The journal currently holds a Q3 ranking in various categories, reflecting its pivotal role in the research community, while not currently offering open access, it remains an essential reference for scholars advancing the techniques utilized in medical imaging and treatment. By fostering a platform for high-quality research, it aims to bridge the gap between theoretical studies and clinical applications, making it a vital addition to any medical library.

RADIATION RESEARCH is a prestigious journal published by the RADIATION RESEARCH SOC that serves as a vital resource for professionals and researchers in the fields of biophysics, radiation science, and radiology. Established in 1954, this journal has consistently advanced the study of radiation's effects on health and the environment, bridging fundamental and applied research. It boasts an impressive impact factor reflected in its quartile rankings, including Q2 in Biophysics and Q1 in Radiation, making it a highly regarded publication within its discipline. Researchers will find valuable insights through rigorous peer-reviewed articles that explore innovative methodologies and findings related to radiation exposure, imaging technologies, and the biological consequences of radiation. Although the journal does not currently offer open access, it remains a vital reference for academia and industry, fostering a deeper understanding of radiation sciences and their implications for future research and public health.

Practical Radiation Oncology is a premier journal published by Elsevier Science Inc., focusing on the critically important fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1879-8500, this journal serves as an essential resource for professionals and researchers dedicated to advancing the practice and research of radiation oncology. Established in 2011 and continuing through 2024, it has quickly gained recognition, achieving a prestigious Q2 ranking in Oncology and an exceptional Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. The journal, housed in New York, USA, provides a platform for innovative research and practical insights, aimed at enhancing therapeutic practices and improving patient outcomes. As part of its commitment to fostering scientific dialogue, it also features a range of articles, reviews, and clinical studies that cater to the diverse interests of its readers. Hard-copy availability combined with digital access ensures a broad reach for the latest advancements in the field.

Radiotherapy and Oncology is a leading peer-reviewed journal published by Elsevier Ireland Ltd, focusing on the vital fields of hematology, oncology, and radiology. With an impressive impact factor and ranking in the top quartiles (Q1) of its categories as of 2023, it is recognized for disseminating high-quality research that contributes significantly to advancements in cancer treatment and patient care. The journal, which has been in circulation since 1983, aims to provide a platform for original research articles, reviews, and clinical studies that explore the latest innovations in radiotherapeutic technologies and oncology practices. This journal is essential for researchers, healthcare professionals, and students who are dedicated to improving cancer therapies and outcomes. Although it does not offer open access, the wealth of information contained within its pages supports continued education and development in these crucial medical fields.

RADIOPROTECTION, published by EDP SCIENCES S A, stands as a pivotal journal in the multidisciplinary fields of Nuclear Energy, Public Health, and Environmental Safety. With an ISSN of 0033-8451 and an E-ISSN of 1769-700X, this journal delves into the crucial aspects of radiation protection and its interactions with health and environment, providing a platform for researchers and professionals to disseminate their findings and insights. Despite being classified in the Q4 quartile for Health, Toxicology and Mutagenesis in 2023, its Q3 status in prestigious categories such as Nuclear Energy and Engineering, and Public Health, underscores its relevance in contemporary academic discourse. The journal continues to expand its cachet with converged years of publication from 1977 to 1981 and 1988 to 2024, ensuring a rich history of scholarly contributions. Access options for interested readers include traditional subscriptions, allowing for comprehensive engagement with a broad range of topics surrounding safety, sustainability, and risk management. Whether you are a researcher, professional, or student, RADIOPROTECTION serves as an essential resource for expanding understanding and fostering innovation within its field.

Journal of Radiotherapy in Practice is a peer-reviewed journal published by Cambridge University Press, focusing on the evolving field of radiotherapy and its application in clinical practice. With ISSN 1460-3969 and E-ISSN 1467-1131, this journal serves as a critical platform for researchers, clinicians, and students in oncology and radiology, providing vital insights into treatment methodologies, patient care, and innovative practices. Although indexed in Q4 quartiles for both Oncology and Radiology, Nuclear Medicine and Imaging, the journal plays an essential role in disseminating clinical findings and advancing the science of radiotherapy since its inception in 1999. Authors are encouraged to contribute their research, case studies, and reviews that align with the journal's objectives, fostering a collaborative environment for sharing knowledge. Despite its current rankings, the journal aims to enhance its impact and visibility in the scientific community, thereby enriching professional practice and patient outcomes in the realm of radiotherapy.

RADIATION PHYSICS AND CHEMISTRY, published by Pergamon-Elsevier Science Ltd in the United Kingdom, stands as a leading journal in the field of radiation studies, bridging fundamental research and practical applications. With an impressive 2023 Scopus Rank of 11 out of 58 in the Radiation category, reflecting an 81st percentile ranking, the journal maintains a robust reputation within the scientific community. The journal focuses on the experimental and theoretical aspects of radiation physics, chemistry, and their interdisciplinary applications, providing critical insights that aid the advancement of knowledge in various domains, including nuclear energy, materials science, and healthcare. Although open access options are not available, the journal garners substantial readership and engagement from researchers, professionals, and students alike, as it publishes innovative studies and reviews from 1985 through to its anticipated conclusion in 2025. The ISSN for the journal is 0969-806X, with the E-ISSN being 1879-0895, ensuring global accessibility to cutting-edge research in radiation science.

Advances in Radiation Oncology, published by Elsevier Inc, is a premier international journal dedicated to the field of oncology and radiology, focusing on the latest groundbreaking research and innovations in radiation therapy. Launched as an Open Access journal in 2016, it has since carved out a significant niche in the academic community, featuring contributions that span a diverse range of topics including clinical practices, technologies, and outcomes in radiation oncology. With an impressive Q2 rankingOncology and Radiology, Nuclear Medicine and Imaging categories for 2023, and positioned within the 65th and 55th percentiles of Scopus ranks, it serves as an essential resource for researchers, medical professionals, and students alike. The journal not only emphasizes the importance of disseminating knowledge widely through its open access model but also aims to foster collaboration and innovation in the evolving landscape of cancer treatment. For those looking to stay at the forefront of radiotherapy research and advancements, Advances in Radiation Oncology is an invaluable platform for scholarly communication.